We are SmallCaps.Us

  • Smallcaps is an online platform that introduces and follows-up high potential U.S. and Canadian small cap stocks.
  • We publish unique content about those companies every Saturday.
  • Why you should sign up for our newsletter? Because an average gain of 210% since 2003 proves that our small cap picks are also perfect for your portfolio.

Latest Articles

Swine Flu And Its Consequences

The World Health Organization (WHO) will hold an emergency meeting today (Saturday, April 25, 2009) to discuss a deadly swine flu strain outbreak in Mexico and the United States. The WHO’s director-general, Margaret Chan, said the outbreak of the never-before-seen virus is a very serious situation and has “pandemic potential.” But she said it is still too early to tell […]

Read more

A Little Lie… And Its Consequences

On Wednesday, James Reindl, Chairman, Director and CEO of TechPrecision Corp. (TPCS) resigned. The press release stated: “Mr. Reindl submitted his resignation and confirmed that despite briefly attending the University of Delaware, he did not receive a degree from the University of Delaware as he had previously represented.” When I visited the TPCS website, Mr. Reindl’s profile was already gone. […]

Read more

Hemispherx Biopharma: One Step Closer

Last week, Dr. Strayer, Hemispherx Biopharma’s (NYSE Alternext US: HEB) Medical Director, presented new cytokine and cardiovascular data at the 9th International IACFS/ME conference. This week, Dr. Strayer and Dr Carter, Hemispherx’ CEO, held a conference call in which they gave an update on the Company’s FDA progress and the new released data. In my previous Hemispherx update, which was […]

Read more

Boots & Coots (WEL) FY2008 Update

Earlier in the week, Boots & Coots International Well Control, Inc. (NYSE Alternext US: WEL) reported very strong fourth quarter and year end results. Revenues for 2008 increased 99% to $209.2 million compared to $105.3 million for the prior year. Net income attributable to common stockholders increased 177% to $21.8 million, or $0.28 per diluted share, compared to $7.9 million, […]

Read more
1 116 117 118 119